Get the Stockscreener App
42.89
0.12%
0.05
After Hours:
42.90
0.010
+0.02%
Veracyte Inc stock is traded at $42.89, with a volume of 804.00K.
It is up +0.12% in the last 24 hours and up +29.85% over the past month.
See More
Previous Close:
$42.84
Open:
$43.25
24h Volume:
804.00K
Relative Volume:
1.05
Market Cap:
$1.74B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-107.22
EPS:
-0.4
Net Cash Flow:
$40.13M
1W Performance:
+9.41%
1M Performance:
+29.85%
6M Performance:
+106.20%
1Y Performance:
+62.65%
1-Day Range:
$42.35
$44.16
1-Week Range:
$38.13
$44.16
52-Week Range:
$18.61
$44.16
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.89 | 1.74B | 399.58M | -54.04M | 40.13M | -0.40 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Veracyte Stock Soars to 52-Week High, Hits $41.46 By Investing.com - Investing.com Nigeria
Fisher Asset Management LLC Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Stock Soars to 52-Week High, Hits $41.46 - Investing.com India
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Advantage Alpha Capital Partners LP - MarketBeat
Algert Global LLC Raises Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Principal Financial Group Inc. Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Position Cut by Jennison Associates LLC - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Position Boosted by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Insider Sell Alert: Karin Eastham Sells 14,731 Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte director Karin Eastham sells shares worth $564,768 By Investing.com - Investing.com Nigeria
Veracyte director Karin Eastham sells shares worth $564,768 - Investing.com
Segall Bryant & Hamill LLC Has $15.12 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Phocas Financial Corp. Invests $1.79 Million in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Inc (VCYT) Trading 2.14% Higher on Nov 19 - GuruFocus.com
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised - MSN
Morgan Stanley Increases Veracyte (NASDAQ:VCYT) Price Target to $28.00 - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Assetmark Inc. - MarketBeat
State of New Jersey Common Pension Fund D Has $2.09 Million Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte initiated with an Outperform at Wolfe on growth, margin potential - TipRanks
First Week of January 2025 Options Trading For Veracyte (VCYT) - Nasdaq
Veracyte (NASDAQ:VCYT) Now Covered by Wolfe Research - MarketBeat
Wolfe Research sets stock target on Veracyte, cites growth potential - Investing.com India
Veracyte initiated with an Outperform at Wolfe Research - TipRanks
Insider Sale: CFO Rebecca Chambers Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte CFO Rebecca Chambers sells $585,663 in company stock - Investing.com
Veracyte director Robert Epstein sells $574,830 in stock - Investing.com
Sumitomo Mitsui Trust Group Inc. Cuts Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Artisan Partners Limited Partnership Bolsters Stake in Veracyte Inc - GuruFocus.com
Veracyte, Inc. (NASDAQ:VCYT) Is About To Turn The Corner - Simply Wall St
Peregrine Asset Advisers Inc. Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Analysts Set Veracyte, Inc. (NASDAQ:VCYT) PT at $39.71 - MarketBeat
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Wellington Management Group LLP's Strategic Reduction in Veracyte Inc Holdings - GuruFocus.com
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates - MSN
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Scotiabank Analyst Says - MarketBeat
Veracyte price target raised to $44 from $40 at Scotiabank - TipRanks
Veracyte, Inc. (NASDAQ:VCYT) Q3 2024 Earnings Call Transcript - Insider Monkey
ARK Investment Management LLC Sells 1,888,552 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte stock target lifted, sustains buy rating on strong Q3 results - Investing.com Australia
Veracyte Third Quarter 2024 Earnings: Beats Expectations - Yahoo Canada Finance
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook By GuruFocus - Investing.com Canada
Earnings call: Veracyte posts record Q3 revenue, raises 2024 guidance By Investing.com - Investing.com Australia
Earnings call: Veracyte posts record Q3 revenue, raises 2024 guidance - Investing.com
Veracyte (NASDAQ:VCYT) Price Target Raised to $38.00 - MarketBeat
Veracyte Inc (VCYT) Shares Up 6.08% on Nov 7 - GuruFocus.com
Veracyte (NASDAQ:VCYT) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Rev - GuruFocus.com
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook - Yahoo Finance
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Veracyte Inc earnings beat by $0.30, revenue topped estimates - Investing.com Australia
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):